Erlotinib in first-line therapy for non-small cell lung cancer: a prospective phase II study.
Year: 2011
Type: article
Study design: Clinical Trial
Source: PubMed
Institutions: Asan Medical Center, University of Ulsan
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2167443158
